RxDoctor Payments DataLook up a doctor →

Judith Betts

Nephrology · Austin, TXNPI 1992735120

Payments from drug & device makers

$3,708,908in general payments, 2019–2025

Across 545 payments — averaging $6805.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$1.7M
  • AstraZeneca$905K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$368K
  • Akebia Therapeutics Inc$270K
  • Astrazeneca UK Limited$220K
  • GSK$146K
  • plus $110K from 21 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring69$1,689,622
AstraZeneca(2 entities)44$905,394
Otsuka Pharmaceutical Development & Commercialization, Inc.19$368,145
Akebia Therapeutics Inc132$270,352
Astrazeneca UK Limited1$219,656
GSK56$145,844
Bayer42$35,997
Novo Nordisk AS64$20,969
Biogen2$19,834
Gilead4$15,098
Hoffmann-la Roche Limited3$13,950
Amgen(2 entities)20$891
Vifor Pharma, Inc.14$747
Aurinia Pharma U.S., Inc.14$713
Otsuka America Pharmaceutical, Inc.22$409
Novo Nordisk4$360
Mallinckrodt Hospital Products Inc.7$274
Daiichi Sankyo Inc.8$153
Calliditas Therapeutics US Inc.1$139
OPKO Pharmaceuticals, LLC7$107
Fresenius USA Marketing, Inc.4$72
Boehringer Ingelheim2$50
Mallinckrodt Enterprises LLC2$38
Novartis1$32
Travere Therapeutics, Inc.1$28
Ultragenyx Pharmaceutical Inc.1$21
Outset Medical Inc1$14

How this compares

$3,708,908 in reported general payments places this provider in the 95th percentile of 1,070 nephrology providers in Texas.

See all nephrology providers in Texas →

Other nephrology in Austin

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →